Jul 21, 2024 · Compare META and RCM stocks to check their AI scores, past performance, fundamental, technical and sentiment indicators, alpha signals, key stock metrics, price, and more.

With unparalleled access to data, intelligent technologies, and advanced analytics – all built and backed by deep RCM experts – we help leading providers transform their approach to financial performance and patient care, today and tomorrow.

Jun 11, 2024 · To gain a panoramic view of R1 RCM's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our...

Jun 28, 2024 · R1 RCM (NASDAQ:RCM) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. Summarizing their recent assessments, the table below...

Nov 5, 2024 · Reports Q3 revenue $656.8M, consensus $634.17M. “R1 continued to successfully execute the onboarding of our newest end-to-end partner while navigating previously disclosed industry and...

R1 RCM rose 5.2% in after-hours trading after receiving a waiver to join with New Mountain Capital for a takeover bid, according to SEC filings.

Accelerate financial and operational improvements for your physician or specialty care practice. We provide revenue cycle management (RCM) solutions for physician groups and specialty care practices in both acute and non-acute care settings.

May 9, 2024 · Daniel Grosslight has given his Buy rating due to a combination of factors that suggest R1 RCM’s recent challenges are temporary and the company’s long-term outlook remains strong.

Our RCM solutions drive sustainable financial performance for today’s top healthcare providers, with an estimated $70 billion in acute care and physician revenue. R1 RCM is a leading …

Oct 30, 2024 · We are the leader in revenue cycle management solutions that transform financial performance and patient care for today’s top healthcare providers.